Loss of heterozygosity at the 5,10-methylenetetrahydrofolate reductase locus in human ovarian carcinomas
1997

Loss of heterozygosity at the MTHFR locus in ovarian cancer

Sample size: 89 publication Evidence: moderate

Author Information

Author(s): A Viel, L Dall'Agnesel, F Simone, V Canzonieri, E Capozzi, MC Visentin, R Valle, M Boiocchi

Primary Institution: Centro di Riferimento Oncologico, Aviano, Italy

Hypothesis

Is there a defect in the MTHFR gene in ovarian tumors that causes increased folate-binding protein expression?

Conclusion

The study found that 59% of ovarian tumors exhibited allelic deletions at the MTHFR locus, suggesting a biochemical defect in folate metabolism.

Supporting Evidence

  • 59% of ovarian tumors showed allelic deletions at the MTHFR locus.
  • No sequence mutations were found in the MTHFR gene.
  • FBP expression was positive in all tested tumors.
  • LOH at the MTHFR locus was associated with decreased enzymatic activity.

Takeaway

Some ovarian cancer cells have a problem with a gene that helps them use folate, which is important for their growth.

Methodology

The study analyzed tumor samples from 89 patients with non-mucinous ovarian carcinoma for MTHFR gene mutations and FBP expression.

Limitations

The study did not confirm whether MTHFR is the target gene of the chromosomal loss.

Participant Demographics

Patients with non-mucinous ovarian carcinoma who underwent surgery.

Statistical Information

P-Value

0.001

Statistical Significance

p=0.001

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication